CTD Holdings Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.06 |
Market Cap |
$33.77 M |
Shares Outstanding |
91.26 M |
Public Float |
42.56 M |
Address |
6714 NW 16th Street Gainesvile Florida 32563 United States |
Employees | - |
Website | http://www.ctd-holdings.com |
Updated | 07/08/2019 |
CTD Holdings, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The company was founded by C. |